JCB, Volume 24, Number 2, 2018 Commentary Vol.24 No. 2 (2018) Effective Leadership through Bioentrepreneurship and Bioinnovation Claudine Kearney For biotechnology firms need leaders that can lead scientists beyond the science and turn new discoveries into commercially viable products. Bioentrepreneurial leaders are continuous lear Commentary Vol.24 No. 2 (2018) Patients Suffer While the Science Establishment Resists Innovative Therapies Henry I. Miller Human gene therapy has been up to now of a type that affects only the patient being treated; it has not modified sperm or eggs cells or embryos in a way that would constitute “germ line Article Vol.24 No. 2 (2018) Turbulence in the Biotechnology Sub-sector of the Western Cape Regional Innovation System Ramazan Uctu The research was initially designed to complete the study with an investigation of the growth stories of the biotechnology spin-offs from the universities in the study. When it became evi Article Vol.24 No. 2 (2018) Evaluation on National Biotechnology Policy (NBP) 2005: Towards Achieving 20 Global Companies In NBP Phase III Shadiya Baqutayan The purpose of this paper is to discuss on the latest progress of the NBP 2005 through selecting significant performance indicators towards the end of policy tenure, which is nurturing 20 Article Vol.24 No. 2 (2018) The Marketing of Genetically Modified Food With Direct and Indirect Consumer Benefits: An Analysis of Willingness to Pay Grant Alexander Wilson Genetically modified foods have traditionally been marketed as having direct industry benefits. Whereas, consumer benefits of genetically modified foods have been largely indirect, t Article Vol.24 No. 2 (2018) Study on the Detection of Total Colony in Medical and Health Environment Based on ATP Bioluminescence Zhe Li In this paper, the application of ATP fluorescence in the detection of colonies in the health environment of hospitals was studied. Firs Article Vol.24 No. 2 (2018) Strategy First, Execution Second: Why Life Science Entrepreneurs Should Adopt a Top-Down Mindset Early Echoe Bouta Despite the dedication of the management team and board to a company’s success, an often overlooked component is the dynamics of the segment in which the company operates. In an effor Intellectual Property Management Vol.24 No. 2 (2018) Patenting Therapeutic Methods: Statutes and Strategies Seema Soni Patenting medical therapeutic methods has become one of the toughest tasks for inventors and scientists in some jurisdictions where these methods are excluded from patentable subject matt Intellectual Property Management Vol.24 No. 2 (2018) Patenting Bioinformatic Inventions: Global Perspective Pratap Devarapalli Patenting bioinformatic inventions has become a ride on the rail to the scientists and inventors. Specifically in bioinformatics, drafting an invention in bounds of patentability criteria is
